I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Rebucci, Magali
24
results:
Search for persons
X
Format
Online (24)
Mediatypes
Articles (Online) (10)
OpenAccess-fulltext (14)
Sorted by: Relevance
Sorted by: Year
?
1
miRNA-196b inhibits cell proliferation and induces apoptosi..:
Rebucci, Magali
;
Sermeus, Audrey
;
Leonard, Elodie
...
Molecular Cancer. 14 (2015) 1 - p. , 2015
Link:
https://doi.org/10.1186/..
?
2
Taxol-induced unfolded protein response activation in breas..:
Notte, Annick
;
Rebucci, Magali
;
Fransolet, Maude
...
The International Journal of Biochemistry & Cell Biology. 62 (2015) - p. 1-14 , 2015
Link:
https://doi.org/10.1016/..
?
3
Differential effect of hypoxia on etoposide‐induced DNA dam..:
Sermeus, Audrey
;
Rebucci, Magali
;
Fransolet, Maude
...
Journal of Cellular Physiology. 228 (2013) 12 - p. 2365-2376 , 2013
Link:
https://doi.org/10.1002/..
?
4
Molecular aspects of cancer cell resistance to chemotherapy:
Rebucci, Magali
;
Michiels, Carine
Biochemical Pharmacology. 85 (2013) 9 - p. 1219-1226 , 2013
Link:
https://doi.org/10.1016/..
?
5
Only Missense Mutations Affecting the DNA Binding Domain of..:
Végran, Frédérique
;
Rebucci, Magali
;
Chevrier, Sandy
...
PLoS ONE. 8 (2013) 1 - p. e55103 , 2013
Link:
https://doi.org/10.1371/..
?
6
Gefitinib and chemotherapy combination studies in five nove..:
Judde, Jean‐Gabriel
;
Rebucci, Magali
;
Vogt, Nicolas
...
International Journal of Cancer. 120 (2007) 7 - p. 1579-1590 , 2007
Link:
https://doi.org/10.1002/..
?
7
Taxol-induced unfolded protein response activation in breas..:
Notte, Annick
;
Rebucci, Magali
;
Fransolet, Maude
...
https://researchportal.unamur.be/en/publications/318a0f3e-eba0-4a2d-ac09-4f178acbe9e7. , 2015
Link:
https://researchportal.u..
?
8
Taxol-induced unfolded protein response activation in breas..:
Notte, Annick
;
Rebucci, Magali
;
Fransolet, Maude
...
https://researchportal.unamur.be/en/publications/318a0f3e-eba0-4a2d-ac09-4f178acbe9e7. , 2015
Link:
https://researchportal.u..
?
9
Evaluation of the interest to combine a CD4 Th1-inducer can..:
Vienot, Angélique
;
Jacquin, Marion
;
Rebucci-Peixoto, Magali
...
BMC Cancer. 23 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
?
10
A Phase II Study Evaluating the Interest to Combine UCPVax,..:
Rebucci-Peixoto, Magali
;
Vienot, Angélique
;
Adotevi, Olivier
...
Frontiers in Oncology. 12 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
11
Phase II INTERACT-ION study: ezabenlimab (BI 754091) and mD..:
Kim, Stefano
;
Boustani, Jihane
;
Vernerey, Dewi
...
Frontiers in Oncology. 12 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
12
Atezolizumab plus modified docetaxel-cisplatin-5-fluorourac..:
Kim, Stefano
;
Buecher, Bruno
;
André, Thierry
...
BMC Cancer. 20 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1186/..
?
13
Only missense mutations affecting the DNA binding domain of..:
Frédérique Végran
;
Magali Rebucci
;
Sandy Chevrier
...
http://europepmc.org/articles/PMC3554672?pdf=render. , 2013
Link:
https://doi.org/10.1371/..
?
14
Evaluation of the interest to combine a CD4 Th1-inducer can..:
Angélique Vienot
;
Marion Jacquin
;
Magali Rebucci-Peixoto
...
https://doi.org/10.1186/s12885-023-11065-0. , 2023
Link:
https://doi.org/10.1186/..
?
15
Phase II INTERACT-ION study: ezabenlimab (BI 754091) and mD..:
Stefano Kim
;
Jihane Boustani
;
Dewi Vernerey
...
https://www.frontiersin.org/articles/10.3389/fonc.2022.918499/full. , 2022
Link:
https://doi.org/10.3389/..
1-15
